The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
A cyclodextrin-capped histone deacetylase inhibitor.EBI
University of Sussex
Integration of lead optimization with crystallography for a membrane-bound ion channel target: discovery of a new class of AMPA receptor positive allosteric modulators.EBI
University of Sussex
Development of dihydropyrrolopyridinone-based PKN2/PRK2 chemical tools to enable drug discovery.EBI
University of Sussex
Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors.EBI
University of Sussex
Development of 2-(4-pyridyl)-benzimidazoles as PKN2 chemical tools to probe cancer.EBI
University of Sussex
Mining Public Domain Data to Develop Selective DYRK1A Inhibitors.EBI
University of Sussex
Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABAEBI
University of Sussex
African trypanosomiasis: Synthesis & SAR enabling novel drug discovery of ubiquinol mimics for trypanosome alternative oxidase.EBI
University of Sussex